Table 3.
Outcomes by disease at baseline and differences with the outcomes in the follow-up
| |
CVR |
COPD |
DMII |
Total sample |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean at baseline (sd) | Mean change (sd) | Range of change across DMPs # | Mean change | Range of change across DMPs # | |
| PACIC (1; 5 highest = best) |
2.80 (0.84) |
0.10** (0.80) |
+0.02; +0.26 |
2.92 (0.89) |
−0.03 (0.75) |
−0.05; +0.06 |
3.29 (0.85) |
−0.23* * (0.72) |
−0.27; − 0.18 |
0.01 (0.78) |
−0.27; +0.26 |
| Physically active days per week |
5.00 (2.07) |
0.33** (2.15) |
−0.23; +0.82 |
4.82 (2.13) |
0.37** (2.20) |
−0.11; +1.36 |
4.74 (1.94) |
0.29 (2.01) |
+0.05; +0.89 |
0.34** (2.14) |
−0.23; +1.36 |
| % smokers |
21 |
−6 pp** |
−2.5 pp; −10.7 pp |
39 |
−11 pp** |
−7.3 pp;-13.7 pp |
22 |
−9 pp** |
−8 pp; −13.6 pp |
−8 pp** |
−13.7 pp; −2.5 pp |
| Self-efficacy (1; 6 highest = best) |
4.45 (0.87) |
−0.28** (0.75) |
−0.33; − 0.15 |
4.33 (0.88) |
−0.34** (0.73) |
−0.48; −0.27 |
4.56 (0.85) |
−0.29** (0.77) |
−0.42; −0.22 |
−0.30** (0.75) |
−0.48; −0.15 |
| EQ-5D (−0.33; 1 highest = best) | 0.83 (0.18) | −0.01* (0.16) | −0.06; +0.03 | 0.79 (0.20) | −0.04** (0.19) | −0.04; − 0.03 | 0.84 (0.16) | −0.03* (0.14) | −0.04; −0.02 | −0.02** (0.17) | −0.06; +0.03 |
pp = percentage points; *(p < 0.05); **(p < 0.01); the differences are calculated subtracting the outcome values at baseline from the outcome values at follow-up.